HPV School Immunisation

Gardasil is the HPV vaccine used in the HSE Schools Immunisation Programme in Ireland since 2010. It is one of several HPV vaccines (i.e., Cervarix, Gardasil/Silgard and Gardasil 9) authorised by the European Commission for use in the EU.

Gardasil is a vaccine, authorised by the European Commission, for the prevention of premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers, anal cancers and genital warts related to Human Papillomavirus (HPV) types 6, 11, 16 and 18. The use of Gardasil in the HSE Schools Immunisation Programme is in accordance with national immunisation guidelines. Further information on the HSE Schools Immunisation Programme for HPV is available on http://www.hse.ie/eng/health/Immunisation/pubinfo/schoolprog/HPV/hpvfacts/

Update: 24 January 2020

Following commentary on social media (beginning 20 January 2020), the HPRA has issued the below statement to provide clarification concerning a report that it received in error:

HPRA confirms no patient fatality in Ireland associated with Gardasil